Abstract:Emerging evidence suggests that accumulation of oxidative DNA damage in nuclear genome is an important contributing factor in neuronal cell death after cerebral ischemia. It has been shown in various models of cerebral ischemia/reperfusion that there is accumulation of oxidative DNA base damage and apurinic/apyridinic abasic site (AP site) in injured neurons, which could mediate neuronal degeneration by triggering various pro-apoptotic molecules. In the brain most types of oxidative DNA damage are repaired via the base-excision repair (BER) pathway that is highly inducible in response to various sublethal stimuli. Thus, interventions that enhance the activity of the BER pathway may be a potential therapeutic strategy against ischemic cell death. In the present study, we have examined the neuroprotective effect of the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) in the rat model of transient global cerebral ischemia. Further, we have investigated the role of BER regulation as a potential mechanism underlying the effect of PACAP. PACAP, when infused intracerebroventricularly in the rat, potently protected against CA1 neuronal cell death after global cerebral ischemia produced by 12 minutes of 4-vessel occlusion. Associated with this neuroprotection, PACAP treatment reduced the accumulation of oxidative DNA lesions, especially AP site, and subsequently attenuated the activation of pro-apoptotic molecules p53 and PUMA in the CA1 sector, suggesting that the effect of PACAP may involve the acceleration of the repair process of endogenous oxidative DNA damage. To investigate the underlying mechanism, cellular BER activity and the expression of BER enzymes were measured in the hippocampal extracts. The results revealed that PACAP markedly enhanced the hippocampal expression (at both mRNA and protein levels) and activities of the essential BER enzymes AP endonuclase (APE) and DNA polymerase-beta. Furthermore, based on the results of inhibition studies, the inducible effect of PACAP on the BER pathway was found to be dependent on the phosphorylation and nuclear translocation of cAMP-response-element-binding protein (CREB), which mediated the enhanced transcription of both APE and DNA polymerase-beta. Finally, the effect of PACAP on BER and neuroprotection was mimicked by the administration of a cAMP/protein kinase A (PKA) agonist. The results of the present study demonstrate the neuroprotective effect of PACAP in hippocampal CA1 neurons after transient global cerebral ischemia. The effect of PACAP is dependent on the activation and nuclear translocation of CREB, and involves CREB-mediated activation of BER pathway for endogenous DNA repair. The results suggest that enhancement of neuronal DNA repair capacity by PACAP or other means may be a novel potential therapeutic approach to limit ischemic neuronal loss. (This project was supported by NIH grants NS36736, NS38560, NS 43802, and NS45048).

Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity

PACAP-Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer's disease

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

Pituitary adenylate cyclase-activating polypeptide attenuates mitochondria-mediated oxidative stress and neuronal apoptosis after subarachnoid hemorrhage in rats

PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis

Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated enhancement of endogenous DNA repair

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models

Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis

ADAM10- and γ-secretase-dependent cleavage of the transmembrane protein PTPRT attenuates neurodegeneration in the mouse model of Alzheimer's disease

Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice.

P2-296: Enhanced Proteolysis of Aβ Peptide Reduces Tau Phosphorylation and Neurofibrillary Tangle Formation in APP/tau Transgenic Mice

A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease

Panaxydol and Panaxynol Protect Cultured Cortical Neurons Against Aβ25–35-induced Toxicity

PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone.

Neuroprotective Effects of Pacap27 in Mice Model of Parkinson'S Disease Involved in the Modulation of K(Atp) Subunits and D2 Receptors in the Striatum

Protection of MCC950 against Alzheimer's disease via inhibiting neuronal pyroptosis in SAMP8 mice

Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.

Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer’s Disease